An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
Rabbani
Shafaat A
SA
Department of Medicine, McGill University, Montreal, Quebec, Canada. shafaat.rabbani@mcgill.ca
Ateeq
Bushra
B
Arakelian
Ani
A
Valentino
Maria Luisa
ML
Shaw
David E
DE
Dauffenbach
Lisa M
LM
Kerfoot
Christopher A
CA
Mazar
Andrew P
AP